Ocular Therapeutix(TM) Receives FDA Agreement Under Special Protocol Assessment (SPA) for its First Pivotal Clinical Trial of OTX-TKI in Wet AMD
Stock Information for Ocular Therapeutix Inc.
Loading
Please wait while we load your information from QuoteMedia.